痴呆症研究中的便携式可及性磁共振成像：关于研究代表性和痴呆友好型技术的伦理考量
Portable Accessible MRI in Dementia Research: Ethical Considerations About Research Representation and Dementia-Friendly Technology.
作者信息
Klein Eran, Duke Han S, Tuite Paul, Taylor Kimberly W, Agarwal Mohit
机构信息
OREGON HEALTH AND SCIENCE UNIVERSITY, PORTLAND, OR, USA.
UNIVERSITY OF SOUTHERN CALIFORNIA, LOS ANGELES, CA, USA.
出版信息
J Law Med Ethics. 2024;52(4):830-839. doi: 10.1017/jme.2024.157. Epub 2025 Jan 31.
Abstract
The introduction of portable MRI (pMRI) has the potential to directly impact dementia research and ultimately clinical care. In this paper, we explore two ethical challenges facing the introduction of pMRI in dementia research. The first is the need to ensure that pMRI enhances rather than undermines efforts aimed at improving ethnoracial representation in dementia research. The second is the need to implement pMRI in dementia research in a dementia-friendly way that attends to the social context and lived experience of people with dementia.
摘要
便携式磁共振成像（pMRI）的引入有可能直接影响痴呆症研究，并最终影响临床护理。在本文中，我们探讨了在痴呆症研究中引入pMRI所面临的两个伦理挑战。第一个挑战是需要确保pMRI能够加强而不是削弱旨在提高痴呆症研究中种族代表性的努力。第二个挑战是需要以一种关注痴呆症患者的社会背景和生活经历的、对痴呆症友好的方式在痴呆症研究中应用pMRI。
相似文献
1
Portable Accessible MRI in Dementia Research: Ethical Considerations About Research Representation and Dementia-Friendly Technology.
J Law Med Ethics. 2024;52(4):830-839. doi: 10.1017/jme.2024.157. Epub 2025 Jan 31.
2
The Need for IRB Leadership to Address the New Ethical Challenges of Research with Highly Portable Neuroimaging Technologies.
J Law Med Ethics. 2024;52(4):840-850. doi: 10.1017/jme.2024.156. Epub 2025 Jan 31.
3
A neuroimaging proof of principle study of Down's syndrome and dementia: ethical and methodological challenges in intrusive research.
J Intellect Disabil Res. 2013 Feb;57(2):105-18. doi: 10.1111/j.1365-2788.2011.01495.x. Epub 2011 Nov 2.
4
Conducting Research with Highly Portable MRI in Community Settings: A Practical Guide to Navigating Ethical Issues and ELSI Checklist.
J Law Med Ethics. 2024;52(4):769-785. doi: 10.1017/jme.2024.162. Epub 2025 Jan 31.
5
Operationalising ethical challenges in dementia research-a systematic review of current evidence.
Age Ageing. 2017 Jul 1;46(4):678-687. doi: 10.1093/ageing/afw250.
6
Ethical Oversight and Social Licensing of Portable MRI Research.
J Law Med Ethics. 2024;52(4):851-867. doi: 10.1017/jme.2024.166. Epub 2025 Jan 31.
7
Ethical issues in genomics research in persons with Alzheimer's Disease/Alzheimer's Disease-related dementia (AD/ADRD): a systematic review.
BMC Med Ethics. 2024 Nov 25;25(1):138. doi: 10.1186/s12910-024-01141-w.
8
Ethical considerations in research studies.
Medsurg Nurs. 2014 Jan-Feb;23(1):54-5.
9
Informed consent for research involving people with dementia: a grey area.
Contemp Nurse. 2010 Feb-Mar;34(2):230-6. doi: 10.5172/conu.2010.34.2.230.
10
Expert Stakeholder Perspectives on Emerging Technology for Neuroimaging Research with Highly Portable MRI: The Need for Guidance on Ethical, Legal, and Societal Issues.
J Law Med Ethics. 2024;52(4):786-804. doi: 10.1017/jme.2024.160. Epub 2025 Jan 31.
引用本文的文献
1
Revolutionizing Brain Research Using Portable MRI in Field Settings: Public Perspectives on the Ethical and Legal Challenges.
Neuroethics. 2025;18(2):36. doi: 10.1007/s12152-025-09606-4. Epub 2025 Jul 26.
2
Socioeconomic Factors in Brain Research: Increasing Sample Representativeness with Portable MRI.
J Law Med Ethics. 2024;52(4):824-829. doi: 10.1017/jme.2024.168. Epub 2025 Jan 31.
本文引用的文献
1
The Realization of Portable MRI for Indigenous Communities in the USA and Canada.
J Law Med Ethics. 2024;52(4):816-823. doi: 10.1017/jme.2024.159. Epub 2025 Jan 31.
2
Ethical, legal, and policy challenges in field-based neuroimaging research using emerging portable MRI technologies: guidance for investigators and for oversight.
J Law Biosci. 2024 Jun 7;11(1):lsae008. doi: 10.1093/jlb/lsae008. eCollection 2024 Jan-Jun.
3
Developing a dementia friendly approach to consent in dementia research.
Aging Ment Health. 2024 Jan-Feb;28(2):294-301. doi: 10.1080/13607863.2023.2264216. Epub 2024 Jan 31.
4
Role of Registries in Medicare Coverage of New Alzheimer Disease Drugs.
JAMA. 2023 Oct 10;330(14):1331-1332. doi: 10.1001/jama.2023.17131.
5
Quantification of race/ethnicity representation in Alzheimer's disease neuroimaging research in the USA: a systematic review.
Commun Med (Lond). 2023 Jul 25;3(1):101. doi: 10.1038/s43856-023-00333-6.
6
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239.
7
Delivering person-centred dementia care: Perceptions of radiography practitioners within diagnostic imaging and radiotherapy departments.
Dementia (London). 2023 Oct;22(7):1586-1603. doi: 10.1177/14713012231189061. Epub 2023 Jul 14.
8
Barriers and solutions to Alzheimer's disease clinical trial participation for Black Americans.
Alzheimers Dement (N Y). 2023 Jul 4;9(3):e12402. doi: 10.1002/trc2.12402. eCollection 2023 Jul-Sep.
9
Lecanemab: Appropriate Use Recommendations.
J Prev Alzheimers Dis. 2023;10(3):362-377. doi: 10.14283/jpad.2023.30.
10
Low-field MRI: A report on the 2022 ISMRM workshop.
Magn Reson Med. 2023 Oct;90(4):1682-1694. doi: 10.1002/mrm.29743. Epub 2023 Jun 22.
Zotero 插件